The proposed research will examine various aspects of the posttranscriptional regulation by Ca2+ or PRL gene expression in the GH3 cell. The basic experimental paradigm for the proposed research is the culture of GH3 cells in a chemically-defined, low Ca2+, serum-free medium (SFM) with or without 0.5 mM CaCl2, which results in low and high levels, respectively, of cytoplasmic PRL mRNA. The effects of Ca2+ on the levels of spliced and unspliced PRL mRNA, and on the rats of transcription from the endogenous PRL gene, and from several PRL gene constructs in transient transfection assays. These experiments will determine whether the posttranscriptional effects of Ca2+ on PRL mRNA occur in the nucleus, and whether Ca2+ influences the rate of splicing of the PRL precursor mRNA. The effects of Ca2+ on cytoplasmic PRL mRNA degradation will be assessed by 3H-uridine pulse-chase experiments. The RNA sequence which confers the highly-specific effect of Ca2+ on PRL mRNA, referred to as the Ca2+-dependent RNA regulatory element (CaRRE), will be searched for by transient transfection assays of PRL-globin fusion gene constructs. Preliminary studies indicate that Ca2+ induces constructs containing the 5' end of the PRL gene, and thus, the proposed studies will concentrate on searching for the CaRRe within this region of the corresponding mRNA. The RNA gel shift and UV crosslinking approaches will be used to search for either nuclear or cytosolic factors which bind specifically to the CaRRE. The effects of Ca2+ on possible modifications of this factor will then be examined. Finally, the role of the ubiquitous Ca2+- binding protein, calmodulin, in the Ca2+ regulation of the PRL gene expression will be examined by establishing permanent transfected cell lines which harbor an inducible calmodulin gene in the """"""""sense"""""""" and """"""""antisense"""""""" orientations. These experiments will allow us to examine the effects, if any, of the overproduction and underproduction of calmodulin on the ability of Ca2+ to stimulate PRL gene expression.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK043064-03
Application #
3244347
Study Section
Biochemical Endocrinology Study Section (BCE)
Project Start
1990-07-01
Project End
1994-06-30
Budget Start
1992-07-01
Budget End
1994-06-30
Support Year
3
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Connecticut
Department
Type
Schools of Dentistry
DUNS #
City
Farmington
State
CT
Country
United States
Zip Code
06030
Heinrich, C A; Lail-Trecker, M R; Peluso, J J et al. (1999) Negative regulation of N-cadherin-mediated cell-cell adhesion by the estrogen receptor signaling pathway in rat pituitary GH3 cells. Endocrine 10:67-76
Billis, W M; White, B A (1997) Effects of the protein tyrosine kinase inhibitor, herbimycin A, on prolactin gene expression in GH3 and 235-1 pituitary tumor cells. Biochim Biophys Acta 1358:31-8
Lail-Trecker, M (1997) Cloning PCR products utilizing the T/A overhang and a kit. Methods Mol Biol 67:79-87
Delidow, B C; Lynch, J P; Peluso, J J et al. (1996) Polymerase chain reaction. Methods Mol Biol 58:275-92
Delidow, B C; Lail-Trecker, M; White, B A (1992) Effects of calcium and calcium ionophores on prolactin gene expression in GH3 and 235-1 rat pituitary tumor cells. Mol Endocrinol 6:1268-76
Billis, W M; Delidow, B C; White, B A (1992) Posttranscriptional regulation of prolactin (PRL) gene expression in PRL-deficient pituitary tumor cells. Mol Endocrinol 6:1277-84
Delidow, B C; Billis, W M; Agarwal, P et al. (1991) Inhibition of prolactin gene transcription by transforming growth factor-beta in GH3 cells. Mol Endocrinol 5:1716-22